Molecular ultrasound assessment of tumor angiogenesis

Angiogenesis

Volumn 13, Issue 2, 2010, Pages 175-188

  Deshpande, Nirupama ^a   Pysz, Marybeth A ^a   Willmann, Jürgen K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Anti angiogenic therapy; Cancer; Endoglin; Imaging; Integrin; Molecular imaging; Molecular ultrasound; Targeted contrast enhanced ultrasound; Tumor; VEGF

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; B 204111; BEVACIZUMAB; CONTRAST MEDIUM; ENDOGLIN; FLUOROCARBON; GADOLINIUM; GEMCITABINE; INTEGRIN; MACROGOL; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MOLECULAR MARKER; NITROGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; SULFUR HEXAFLUORIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

COLON CANCER; CONTRAST ENHANCEMENT; DRUG TARGETING; ECHOGRAPHY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; METASTASIS POTENTIAL; MICROBUBBLE; MOLECULAR IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; HUMANS; MOLECULAR IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL; ULTRASONICS;

EID: 77955660462     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-010-9175-z     Document Type: Review

References (97)

1. G Bergers LE Benjamin 2003 Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 401 410 10.1038/nrc1093 12778130 (Pubitemid 37328844)
2. K Red-Horse N Ferrara 2006 Imaging tumor angiogenesis J Clin Invest 116 2585 2587 10.1172/JCI30058 17016553 (Pubitemid 44511620)
3. W Risau I Flamme 1995 Vasculogenesis Annu Rev Cell Dev Biol 11 73 91 10.1146/annurev.cb.11.110195.000445 8689573
4. GH Algire HW Chalkley FY Legallais HD Park 1945 Vascular reactions of normal and malignant tumors in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants J Natl Cancer Inst 6 73 85
5. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31 10.1038/nm0195-27 7584949
6. N Ferrara RS Kerbel 2005 Angiogenesis as a therapeutic target Nature 438 967 974 10.1038/nature04483 16355214 (Pubitemid 43093963)
7. J Folkman 2006 Angiogenesis Annu Rev Med 57 1 18 10.1146/annurev.med.57. 121304.131306 16409133 (Pubitemid 43261975)
8. M Abdelrahim S Konduri R Basha PA Philip CH Baker 2010 Angiogenesis: an update and potential drug approaches (review) Int J Oncol 36 5 18 19956828
9. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 1011 1027 10.1200/JCO.2005.06.081 15585754 (Pubitemid 46202320)
10. PC Brooks RA Clark DA Cheresh 1994 Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 569 571 10.1126/science.7512751 7512751
11. C Bernabeu JM Lopez-Novoa M Quintanilla 2009 The emerging role of TGF-beta superfamily coreceptors in cancer Biochim Biophys Acta 1792 954 973 19607914
12. N Ferrara 2002 Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications Semin Oncol 29 10 14 12516033
13. Ferrara N (2005) The role of VEGFR in the regulation of physiological and pathological angiogenesis. In: Clauss M, Breier G (eds) Mechanisms of angiogenesis. Birkhaeuser Basel Press, Switzerland, pp 209-231
14. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 581 611 10.1210/er.2003-0027 15294883 (Pubitemid 39099316)
15. RA Brekken PE Thorpe 2001 VEGF-VEGF receptor complexes as markers of tumor vascular endothelium J Control Release 74 173 181 10.1016/S0168-3659(01) 00333-9 11489493 (Pubitemid 32727619)
16. K Paz Z Zhu 2005 Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective Front Biosci 10 1415 1439 10.2741/1629 15769635
17. JS Desgrosellier DA Cheresh 2010 Integrins in cancer: biological implications and therapeutic opportunities Nat Rev Cancer 10 9 22 10.1038/nrc2748 20029421
18. W Cai X Chen 2006 Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism Anticancer Agents Med Chem 6 407 428 10.2174/ 187152006778226530 17017851
19. TH Stollman TJ Ruers WJ Oyen OC Boerman 2009 New targeted probes for radioimaging of angiogenesis Methods 48 188 192 10.1016/j.ymeth.2009.03.006 19318127
20. P Castellani G Viale A Dorcaratto G Nicolo J Kaczmarek, et al. 1994 The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis Int J Cancer 59 612 618 10.1002/ijc.2910590507 7525495 (Pubitemid 24358583)
21. B Carnemolla P Castellani M Ponassi L Borsi S Urbini, et al. 1999 Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody Am J Pathol 154 1345 1352 10329587
22. M Silacci SS Brack N Spath A Buck S Hillinger, et al. 2006 Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo Protein Eng Des Sel 19 471 478 10.1093/protein/gzl033 16928692 (Pubitemid 44408907)
23. E Fonsatti M Altomonte P Arslan M Maio 2003 Endoglin (CD105): a target for anti-angiogenetic cancer therapy Curr Drug Targets 4 291 296 10.2174/1389450033491073 12699349 (Pubitemid 36443247)
24. X Ma M Labinaz J Goldstein H Miller WJ Keon, et al. 2000 Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration Arterioscler Thromb Vasc Biol 20 2546 2552 11116051
25. MG Kolonin 2009 Tissue-specific targeting based on markers expressed outside endothelial cells Adv Genet 67 61 102 10.1016/S0065-2660(09)67003-6 19914450
26. JS Hardwick Y Yang C Zhang B Shi R McFall, et al. 2005 Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling Mol Cancer Ther 4 413 425 15767550
27. SS Chang DS O'Keefe DJ Bacich VE Reuter WD Heston, et al. 1999 Prostate-specific membrane antigen is produced in tumor-associated neovasculature Clin Cancer Res 5 2674 2681 10537328
28. RE Conway N Petrovic Z Li W Heston D Wu, et al. 2006 Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction Mol Cell Biol 26 5310 5324 10.1128/MCB.00084-06 16809768 (Pubitemid 44036201)
29. L Huminiecki M Gorn S Suchting R Poulsom R Bicknell 2002 Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis Genomics 79 547 552 10.1006/geno.2002.6745 11944987 (Pubitemid 34274296)
30. P Seth Y Lin J Hanai V Shivalingappa MP Duyao, et al. 2005 Magic roundabout, a tumor endothelial marker: expression and signaling Biochem Biophys Res Commun 332 533 541 10.1016/j.bbrc.2005.03.250 15894287 (Pubitemid 40725009)
31. H Sheldon M Andre JA Legg P Heal JM Herbert, et al. 2009 Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors FASEB J 23 513 522 10.1096/fj.07-098269 18948384
32. NI Herath MD Spanevello S Sabesan T Newton M Cummings, et al. 2006 Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival BMC Cancer 6 144 10.1186/1471-2407-6-144 16737551 (Pubitemid 44057312)
33. J Chen G Zhuang L Frieden W Debinski 2008 Eph receptors and Ephrins in cancer: common themes and controversies Cancer Res 68 10031 10033 10.1158/0008-5472.CAN-08-3010 19074866
34. Q Wu Z Suo GB Kristensen M Baekelandt JM Nesland 2006 The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma Gynecol Oncol 102 15 21 10.1016/j.ygyno.2005.11.034 16499955 (Pubitemid 43851053)
35. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545 10.1016/S0140-6736(00)04046-0 11229684 (Pubitemid 32173595)
36. C Porta P Larghi M Rimoldi MG Totaro P Allavena, et al. 2009 Cellular and molecular pathways linking inflammation and cancer Immunobiology 214 761 777 10.1016/j.imbio.2009.06.014 19616341
37. F Colotta P Allavena A Sica C Garlanda A Mantovani 2009 Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 1073 1081 10.1093/carcin/bgp127 19468060
38. DA Mankoff 2007 A definition of molecular imaging J Nucl Med 48 18N 17536102 21N
39. TE Peterson HC Manning 2009 Molecular imaging: 18F-FDG PET and a whole lot more J Nucl Med Technol 37 151 161 10.2967/jnmt.109.062729 19692452
40. IM Burtscher S Holtas 2001 Proton MR spectroscopy in clinical routine J Magn Reson Imaging 13 560 567 10.1002/jmri.1079 11276100 (Pubitemid 32231510)
41. B Robert 2009 Resonance Raman spectroscopy Photosynth Res 101 147 155 10.1007/s11120-009-9440-4 19568956
42. C Krafft G Steiner C Beleites R Salzer 2009 Disease recognition by infrared and Raman spectroscopy J Biophotonics 2 13 28 10.1002/jbio.200810024 19343682
43. RK Sahu S Mordechai 2005 Fourier transform infrared spectroscopy in cancer detection Future Oncol 1 635 647 10.2217/14796694.1.5.635 16556041
44. DI Ellis WB Dunn JL Griffin JW Allwood R Goodacre 2007 Metabolic fingerprinting as a diagnostic tool Pharmacogenomics 8 1243 1266 10.2217/14622416.8.9.1243 17924839 (Pubitemid 47578232)
45. M Pysz SS Gambhir JK Willmann 2010 Molecular Imaging: current status and emerging strategies Clin Radiol 65 500 515 10.1016/j.crad.2010.03.011 20541650
46. O Schnell B Krebs J Carlsen I Miederer C Goetz, et al. 2009 Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography Neuro Oncol 11 861 870 10.1215/15228517-2009-024 19401596
47. I Dijkgraaf OC Boerman 2009 Radionuclide imaging of tumor angiogenesis Cancer Biother Radiopharm 24 637 647 10.1089/cbr.2009.0694 20025543
48. JK Willmann Z Cheng C Davis AM Lutz ML Schipper, et al. 2008 Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice Radiology 249 212 219 10.1148/radiol.2491072050 18695212
49. CH Contag 2007 In vivo pathology: seeing with molecular specificity and cellular resolution in the living body Annu Rev Pathol 2 277 305 10.1146/annurev.pathol.2.010506.091930 18039101 (Pubitemid 46448067)
50. TD Wang S Friedland P Sahbaie R Soetikno PL Hsiung, et al. 2007 Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology Clin Gastroenterol Hepatol 5 1300 1305 10.1016/j.cgh.2007.07.013 17936692 (Pubitemid 350027770)
51. HL Kim 2009 Optical imaging in oncology Urol Oncol 27 298 300 19414116
52. WA Ritchie W Thompson 1979 A clinical assessment of real time ultrasound Ir J Med Sci 148 251 254 10.1007/BF02938093 544545
53. N Deshpande A Needles JK Willmann 2010 Molecular ultrasound imaging: current status and future directions Clin Radiol 65 567 581 10.1016/j.crad.2010. 02.013 20541656
54. SR Wilson HJ Jang TK Kim H Iijima N Kamiyama, et al. 2008 Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography AJR Am J Roentgenol 190 691 695 10.2214/AJR.07.3116 18287440 (Pubitemid 351304513)
55. N Celli S Gaiani F Piscaglia G Zironi V Camaggi, et al. 2007 Characterization of liver lesions by real-time contrast-enhanced ultrasonography Eur J Gastroenterol Hepatol 19 3 14 10.1097/01.meg.0000250585.53608.3c 17206071 (Pubitemid 46066862)
56. HP Weskott 2008 Emerging roles for contrast-enhanced ultrasound Clin Hemorheol Microcirc 40 51 71 18791267
57. AC Perkins M Frier AJ Hindle PE Blackshaw SE Bailey, et al. 1997 Human biodistribution of an ultrasound contrast agent (Quantison) by radiolabelling and gamma scintigraphy Br J Radiol 70 603 611 9227254
58. AL Klibanov 2009 Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging Med Biol Eng Comput 47 875 882 10.1007/s11517-009-0498-0 19517153
59. AL Klibanov MS Hughes FS Villanueva RJ Jankowski WR Wagner, et al. 1999 Targeting and ultrasound imaging of microbubble-based contrast agents MAGMA 8 177 184 10.1007/BF02594596 10504045
60. AL Klibanov 2005 Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging Bioconjug Chem 16 9 17 10.1021/bc049898y 15656569 (Pubitemid 40129671)
61. S Pochon I Tardy P Bussat T Bettinger J Brochot, et al. 2010 BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis Invest Radiol 45 89 95 10.1097/RLI.0b013e3181c5927c 20027118
62. Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M et al. (2010) Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology. doi: 10.1148/radiol.10091858
63. JK Willmann RH Kimura N Deshpande AM Lutz JR Cochran, et al. 2010 Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides J Nucl Med 51 433 440 10.2967/jnumed.109.068007 20150258
64. RH Kimura Z Cheng SS Gambhir JR Cochran 2009 Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects Cancer Res 69 2435 2442 10.1158/0008-5472.CAN-08-2495 19276378
65. RH Kimura AM Levin FV Cochran JR Cochran 2009 Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity Proteins 77 359 369 10.1002/prot.22441 19452550
66. HY Jun SH Park HS Kim KH Yoon 2010 Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model Acad Radiol 17 54 60 10.1016/j.acra.2009.07.017 19815430
67. JK Willmann AM Lutz R Paulmurugan MR Patel P Chu, et al. 2008 Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo Radiology 248 936 944 10.1148/radiol.2483072231 18710985
68. R Pillai ER Marinelli RE Swenson 2006 A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups Biopolymers 84 576 585 10.1002/bip.20570 16845666 (Pubitemid 44935257)
69. R Pillai ER Marinelli H Fan P Nanjappan B Song, et al. 2010 A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis Bioconjug Chem 21 556 562 10.1021/bc9005688
70. G Korpanty JG Carbon PA Grayburn JB Fleming RA Brekken 2007 Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin Cancer Res 13 323 330 10.1158/1078-0432.CCR-06-1313 17200371 (Pubitemid 46121886)
71. D Marshall RB Pedley JA Boden R Boden RG Melton, et al. 1996 Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody Br J Cancer 73 565 572 8605088
72. W Cai X Chen 2008 Multimodality molecular imaging of tumor angiogenesis J Nucl Med 49 Suppl 2 113S 128S 10.2967/jnumed.107.045922 18523069 (Pubitemid 351948040)
73. W Cai SS Gambhir X Chen 2008 Chapter 7. Molecular imaging of tumor vasculature Methods Enzymol 445 141 176 10.1016/S0076-6879(08)03007-3 19022059
74. Z Miao G Ren H Liu RH Kimura L Jiang, et al. 2009 An engineered knottin peptide labeled with 18F for PET imaging of integrin expression Bioconjug Chem 20 2342 2347 10.1021/bc900361g 19908826
75. G Hu M Lijowski H Zhang KC Partlow SD Caruthers, et al. 2007 Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles Int J Cancer 120 1951 1957 10.1002/ijc.22581 17278104 (Pubitemid 46418372)
76. C Zhang M Jugold EC Woenne T Lammers B Morgenstern, et al. 2007 Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner Cancer Res 67 1555 1562 10.1158/0008-5472.CAN-06-1668 17308094 (Pubitemid 46383379)
77. DB Ellegala H Leong-Poi JE Carpenter AL Klibanov S Kaul, et al. 2003 Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3 Circulation 108 336 341 10.1161/01.CIR.0000080326.15367.0C 12835208 (Pubitemid 36899026)
78. C Zavaleta A de la Zerda Z Liu S Keren Z Cheng, et al. 2008 Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes Nano Lett 8 2800 2805 10.1021/nl801362a 18683988
79. DR Collingridge VA Carroll M Glaser EO Aboagye S Osman, et al. 2002 The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography Cancer Res 62 5912 5919 12384557
80. MV Backer Z Levashova V Patel BT Jehning K Claffey, et al. 2007 Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes Nat Med 13 504 509 10.1038/nm1522 17351626 (Pubitemid 46559824)
81. WB Nagengast EG de Vries GA Hospers NH Mulder JR de Jong, et al. 2007 In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft J Nucl Med 48 1313 1319 10.2967/jnumed.107.041301 17631557 (Pubitemid 47242797)
82. JK Willmann R Paulmurugan K Chen O Gheysens M Rodriguez-Porcel, et al. 2008 US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice Radiology 246 508 518 10.1148/radiol.2462070536 18180339
83. MV Backer TI Gaynutdinov V Patel AK Bandyopadhyaya BT Thirumamagal, et al. 2005 Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature Mol Cancer Ther 4 1423 1429 10.1158/1535-7163. MCT-05-0161 16170035
84. K Chen ZB Li H Wang W Cai X Chen 2008 Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots Eur J Nucl Med Mol Imaging 35 2235 2244 10.1007/s00259-008-0860-8 18566815
85. DJ Lee A Lyshchik J Huamani DE Hallahan AC Fleischer 2008 Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model J Ultrasound Med 27 855 866 18499845
86. JJ Rychak J Graba AM Cheung BS Mystry JR Lindner, et al. 2007 Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis Mol Imaging 6 289 296 18092513
87. A Lyshchik AC Fleischer J Huamani DE Hallahan M Brissova, et al. 2007 Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography J Ultrasound Med 26 1575 1586 17957052
88. GE Weller MK Wong RA Modzelewski E Lu AL Klibanov, et al. 2005 Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine Cancer Res 65 533 539 15695396
89. M Palmowski J Huppert G Ladewig P Hauff M Reinhardt, et al. 2008 Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects Mol Cancer Ther 7 101 109 10.1158/1535-7163.MCT-07-0409 18202013
90. Cell signaling Technology, Inc. "Angiogenesis", Product Pathways (2010) www.cellsignal.com/pathways/angiogenesis.jsp
91. JK Willmann N van Bruggen LM Dinkelborg SS Gambhir 2008 Molecular imaging in drug development Nat Rev Drug Discov 7 591 607 10.1038/nrd2290 18591980 (Pubitemid 351927724)
92. SK Nune P Gunda PK Thallapally YY Lin ML Forrest, et al. 2009 Nanoparticles for biomedical imaging Expert Opin Drug Deliv 6 1175 1194 10.1517/17425240903229031 19743894
93. E Blanco CW Kessinger BD Sumer J Gao 2009 Multifunctional micellar nanomedicine for cancer therapy Exp Biol Med (Maywood) 234 123 131 10.3181/0808-MR-250
94. DE Sosnovik R Weissleder 2007 Emerging concepts in molecular MRI Curr Opin Biotechnol 18 4 10 10.1016/j.copbio.2006.11.001 17126545 (Pubitemid 46227964)
95. LA Bentolila Y Ebenstein S Weiss 2009 Quantum dots for in vivo small-animal imaging J Nucl Med 50 493 496 10.2967/jnumed.108.053561 19289434
96. H Wang W Cai K Chen ZB Li A Kashefi, et al. 2007 A new PET tracer specific for vascular endothelial growth factor receptor 2 Eur J Nucl Med Mol Imaging 34 2001 2010 10.1007/s00259-007-0524-0 17694307 (Pubitemid 350212131)
97. Barrett T, Choyke PL (2008) Imaging angiogenesis. In: Figg W, Folkman J (eds) Angiogenesis: an integrative approach from science to medicine. Springer Press, US, pp 321-331